| Authors: |
Friedlaender A; Oncology Department, University Hospital Geneva (HUG), Geneva, Switzerland.; Oncology Department, Clinique Générale Beaulieu, Geneva, Switzerland., Subbiah V; Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Russo A; Medical Oncology Unit, A.O. Papardo, Messina, Italy., Banna GL; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Malapelle U; Department of Public Health, University Federico II, Naples, Italy., Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai System & Icahn School of Medicine, Mount Sinai, New York, NY, USA., Addeo A; Oncology Department, University Hospital Geneva (HUG), Geneva, Switzerland. Alfredo.Addeo@hcuge.ch. |